End-Stage Renal Disease Intra-dialysis Lifestyle Education Study (END-IDLE)

July 13, 2017 updated by: Gurjeet Birdee, Vanderbilt University Medical Center
The purpose of this study is to compare the effects of intra-dialysis yoga to an educational program among patients with end-stage renal disease. The investigators hypothesize that yoga as compared to the educational program will significantly improve quality of life.

Study Overview

Detailed Description

The investigators propose a prospective, randomized clinical trial among on maintenance hemodialysis to compare the effects of intra-dialysis yoga to an educational program. In a sample of 68 patients the investigators will compare the clinical effects of a 12-week program of yoga to a 12-week education program during dialysis. Outcome assessment of study participants will occur at baseline, 6-weeks, 12-weeks, and 24 weeks for: disease-related quality of life (physical component primary outcome of the study), physical performance, blood pressure, fatigue, satisfaction with dialysis, sleep quality, and mood. Among a sub-sample of 20 participants, the investigators will measure the potential effects of the interventions on endothelial function, arterial stiffness, and autonomic tone. The sub-study will collect outcomes at baseline and 12 weeks.

Study Type

Interventional

Enrollment (Actual)

67

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Vanderbilt University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Maintenance hemodialysis for ≥3 or months
  • Adequately dialyzed (Kt/V ≥1.2 measured within last 3 months)
  • Expected to remain in present hemodialysis shift for next 4 months
  • Expected to remain on hemodialysis for at least 6 months
  • 18 years or older

Exclusion Criteria:

  • Acute or chronic medical conditions that would make intra-dialysis yoga potentially hazardous
  • Unstable cardiac disease e.g. angina, life threatening arrhythmia
  • Chronic lung disease that prevents gentle exercise or deep breathing exercises
  • Active cerebrovascular disease
  • Major depression
  • Chronic symptoms of nausea, vomiting, or diarrhea
  • Current participation in exercise or mind body program/practice
  • Cognitive impairment (MME ≤ 24) measured at baseline testing visit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intra-dialysis yoga
The experimental intervention in this study is intra-dialysis yoga.
The experimental intervention in this study is intra-dialysis yoga. The intra-dialysis yoga protocol consists of yoga instruction and practice being offered three times a week for 12 weeks. Subjects will have the opportunity to participate in 15 to 60 minutes of yoga during dialysis.
Active Comparator: Educational program
The active comparator for the study is an educational program.
The educational intervention in this study consists of 12 modules of an educational course, Kidney School, developed and maintained by the Medical Education Institute, Inc. Kidney School is a comprehensive, free, educational curriculum for people with kid

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Physical Component Summary of Kidney Disease Quality of Life-36 questionnaire at 6 weeks, 12 weeks, and 24 weeks.
Time Frame: Baseline, 6 weeks, 12 weeks, and 24 weeks
The Kidney Disease Quality of Life-36 instrument is a 36-item instrument that contains a generic core (Short Form-12) plus the burden of kidney disease, symptoms/problem of kidney disease, and effects of kidney disease scales.
Baseline, 6 weeks, 12 weeks, and 24 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Assessment of Chronic Illness Therapy-Fatigue
Time Frame: Baseline, 6, 12, and 24 weeks
Questionnaire to assess fatigue among chronic disease patients
Baseline, 6, 12, and 24 weeks
Profile of Mood States
Time Frame: Baseline, 6, 12, and 24 weeks
Questionnaire to assess emotional states
Baseline, 6, 12, and 24 weeks
Center for Epidemiological Studies Depression
Time Frame: Baseline, 6, 12, and 24 weeks
Questionnaire to assess depressive symptoms
Baseline, 6, 12, and 24 weeks
End-stage renal disease: Patient satisfaction
Time Frame: Baseline, 6, 12, and 24 weeks
Questionnaire to assess patient satisfaction with dialysis treatment
Baseline, 6, 12, and 24 weeks
Pittsburgh Sleep Quality Index
Time Frame: Baseline, 6, 12, and 24 weeks
Questionnaire to assess sleep quality
Baseline, 6, 12, and 24 weeks
Self-efficacy for self-management
Time Frame: Baseline, 6, 12, and 24 weeks
Questionnaire to assess self-efficacy for self-management
Baseline, 6, 12, and 24 weeks
6-minute walk test
Time Frame: Baseline, 12, and 24 weeks
Assessment of physical performance
Baseline, 12, and 24 weeks
Blood pressure
Time Frame: Baseline and weekly over 12 week study period
Baseline and weekly over 12 week study period
Measure of endothelial function with flow-mediated vasodilatation
Time Frame: Baseline and 12-weeks
Sub-set of patients will have this assessment of endothelial function which measures percentage change in diameter measured in millimeters
Baseline and 12-weeks
Measure of arterial stiffness from radial artery based pulse wave analysis
Time Frame: Baseline and 12-weeks
Sub-set of patient will have this assessment of arterial stiffness as augmentation index
Baseline and 12-weeks
Autonomic tone
Time Frame: Baseline and 12-weeks
Assessment of cardiovagal and sympathoneural functioning including baroreflex and heart rate variability
Baseline and 12-weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gurjeet S Birdee, MD MPH, Vanderbilt University Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2015

Primary Completion (Actual)

May 1, 2017

Study Completion (Actual)

May 1, 2017

Study Registration Dates

First Submitted

January 29, 2015

First Submitted That Met QC Criteria

February 10, 2015

First Posted (Estimate)

February 11, 2015

Study Record Updates

Last Update Posted (Actual)

July 18, 2017

Last Update Submitted That Met QC Criteria

July 13, 2017

Last Verified

July 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 141325
  • K23AT006965 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on End-stage Renal Disease

Clinical Trials on Intradialysis-yoga

Subscribe